Table 4.
Author | Aims | Imaging modality | Number, (training (T) and validation (V) set, where available) | Conclusion |
---|---|---|---|---|
Reimer et al. [105] | To determine whether post-treatment MRI-based texture analysis of liver metastases may be suitable for predicting therapy response to transarterial radioembolization (TARE) during follow-up | CEMRI | 37 | The model indicates the potential of MRI-based texture analysis at arterial- and venous-phase MRI for the early prediction of progressive disease after TARE |
Cozzi et al. [106] | To predict overall survival and local control | Non-contrast CT | 138 | Survival could be predicted using a radiomics signature made by a single shape-based feature |
Kim et al. [107] | To predict survival (overall and progression-free survival) | CECT | 88 | A combination of clinical and radiomic features better predicted survival |
Mokrane et al. [108] | To enhance clinicians’ decision-making by diagnosing HCC in cirrhotic patients with indeterminate liver nodules using quantitative imaging features | CECT |
178 T: 142 V: 36 |
Radiomics can be used to non-invasively diagnose HCC in cirrhotic patients with indeterminate liver nodules, which could be used to optimize patient management |
Donghui et al. [13] | To identify aggressive behaviour and predict recurrence of HCC after liver transplantation (LT) | CECT |
133 T: 93 V: 40 |
Radiomics signature extracted from CT images may be a potential imaging biomarker for liver cancer invasion and enable accurate prediction of HCC recurrence after LT |
Zhao et al. [109] | To investigate the combined predictive performance of qualitative and quantitative MRI features and prognostic immunohistochemical markers for the ER of intrahepatic mass-forming cholangiocarcinoma (IMCC) | CEMRI | 47 | The combined model was the superior predictive model of ER |
The columns Aims and Conclusion are directly based on the original work as cited in the column Author (wording partly adapted).
CECT contrast-enhanced computed tomography, ER early recurrence, HCC hepatocellular carcinoma, MRI magnetic resonance imaging, MVI microvascular invasion